Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation
ChemMedChem · 2025
DOI: 10.1002/cmdc.202500487 ↗At a glance
Journal article in ChemMedChem, 2025. Written by Wen Shao and 9 co-authors. Institution: Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First A…. Major MEDLINE topics: Ferroptosis, Indoles, Antioxidants. 36 references. Funded by: The Guangdong Basic and Applied Basic Research Foundation, The National Natural Science Foundation of China, The China Postdoctoral Science Foundation.
Abstract (original language)
Ferroptosis, a form of regulated cell death characterized by excessive lipid peroxidation, has been implicated in various neurological disorders. Ferrostatin‐1 (Fer‐1), a well‐known ferroptosis inhibitor, exhibits therapeutic potential but suffers from poor metabolic stability, limiting its applications. In this study, a phenotype‐based screening of an in‐house compound library is conducted and a novel ferroptosis inhibitor, TJC‐2‐1 , is identified. To optimize its inhibitory activity, a series of 35 indoline derivatives are synthesized and evaluated. Among them, compound 14 exhibits the most potent inhibition against erastin‐induced (EC 50 = 0.15 μM) and RSL3‐induced (EC 50 = 0.15 μM) ferroptosis in HT22 mouse hippocampal cells. Mechanistic investigations reveal that compound 14 functions as a novel radical‐trapping antioxidant, exhibiting lipid peroxidation scavenging capacity comparable to that of Fer‐1. Remarkably, compound 14 demonstrates significantly improved microsomal metabolic stability compared to Fer‐1. These findings suggest that compound 14 has the potential to serve as a lead compound for ferroptosis‐related diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Infectious Diseases, The Key Laboratory of Advanced Interdisciplinary Studies, State Key Laboratory of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, 511436, C…
- University of South China, Hengyang, 421001, China.
- Innovative Center for Pathogen Research, Guangzhou National Laboratory, Guangzhou, 510005, China.
ORCID profiles: Yuying Fang
Funding
- The Guangdong Basic and Applied Basic Research Foundation
- The National Natural Science Foundation of China
- The China Postdoctoral Science Foundation
- The R&D Program of Guangzhou National Laboratory
Cite
APA
Shao, W., Liu, Y., Jiang, D., Xing, Z., Qiao, J., Liu, M., Huang, X., Zhang, R., Fang, Y., & Peng, W. (2025). Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. https://doi.org/10.1002/cmdc.202500487
Vancouver
Shao W, Liu Y, Jiang D, Xing Z, Qiao J, Liu M, et al. Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation. ChemMedChem. 2025. doi:10.1002/cmdc.202500487
BibTeX
@article{Shao2025,
author = {Shao, Wen and Liu, Yuanyuan and Jiang, Deling and Xing, Zhiyang and Qiao, Jiale and Liu, Man and Huang, Xupeng and Zhang, Renyu and Fang, Yuying and Peng, Wei},
title = {Novel Indoline Derivatives as Ferroptosis Inhibitors: Synthesis, Biological Evaluation, and Mechanistic Investigation},
journal = {ChemMedChem},
year = {2025},
doi = {10.1002/cmdc.202500487}
}
EUVIMED